Figure 1.
Th17/Tc17 are a significant source of GM-CSF in the GI tract after allo-SCT. Cytokine and transcription factor expression by CD4+YFP+ and CD8+YFP+ T cells was assessed in the colon and mLN 1, 2, and 4 weeks after allogeneic (B6.IL-17CreRosa26eYFP→Balb/c) transplant. (A) Representative flow cytometry plots gated on isotype controls demonstrating GM-CSF expression in YFP+ vs YFP− T cells 4 weeks after allo-SCT. (B) Frequency of GM-CSF expression in CD4+ and CD8+ T cells within YFP+ and YFP− compartments from colon and mLN at 1, 2, and 4 weeks after allo-SCT. (C) Frequency of YFP expression within CD4+GM-CSF+ and CD8+GM-CSF+ T cells from colon and mLN at 1, 2, and 4 weeks after allo-SCT. (D) Total number of CD4+ GM-CSF+YFP+, GM-CSF+YFP−, and total CD4+ T cells in colon and mLN at 1, 2, and 4 weeks after allo-SCT. (E) Total number of CD8+ GM-CSF+YFP+, GM-CSF+YFP−, and total CD8+ T cells in colon and mLN at 1, 2, and 4 weeks after allo-SCT. (A-E) The data are combined from 3 replicate experiments (n = 14-16 mice per group). (F) Representative histograms showing BATF expression in RORγt+ and RORγt− CD4+ and CD8+ T cell fractions in colon 2 and 4 weeks after allo-SCT. (G) Representative histograms showing BATF expression in GM-CSF+ and GM-CSF− colonic CD4+ T cells fractions 2 and 4 weeks after allo-SCT. (H) Batf relative gene expression in YFP+ and YFP− colonic CD4+ T cells 4 weeks after allo-SCT (n = 6 per group). Statistical analyses were performed by unpaired Student t test when comparing between 2 groups and 1-way analysis of variance when comparing over time (mean ± standard error of the mean [SEM]). *P < .05; **P < .01; ***P < .001; ****P < .0001.

Th17/Tc17 are a significant source of GM-CSF in the GI tract after allo-SCT. Cytokine and transcription factor expression by CD4+YFP+ and CD8+YFP+ T cells was assessed in the colon and mLN 1, 2, and 4 weeks after allogeneic (B6.IL-17CreRosa26eYFP→Balb/c) transplant. (A) Representative flow cytometry plots gated on isotype controls demonstrating GM-CSF expression in YFP+ vs YFP T cells 4 weeks after allo-SCT. (B) Frequency of GM-CSF expression in CD4+ and CD8+ T cells within YFP+ and YFP compartments from colon and mLN at 1, 2, and 4 weeks after allo-SCT. (C) Frequency of YFP expression within CD4+GM-CSF+ and CD8+GM-CSF+ T cells from colon and mLN at 1, 2, and 4 weeks after allo-SCT. (D) Total number of CD4+ GM-CSF+YFP+, GM-CSF+YFP, and total CD4+ T cells in colon and mLN at 1, 2, and 4 weeks after allo-SCT. (E) Total number of CD8+ GM-CSF+YFP+, GM-CSF+YFP, and total CD8+ T cells in colon and mLN at 1, 2, and 4 weeks after allo-SCT. (A-E) The data are combined from 3 replicate experiments (n = 14-16 mice per group). (F) Representative histograms showing BATF expression in RORγt+ and RORγt CD4+ and CD8+ T cell fractions in colon 2 and 4 weeks after allo-SCT. (G) Representative histograms showing BATF expression in GM-CSF+ and GM-CSF colonic CD4+ T cells fractions 2 and 4 weeks after allo-SCT. (H) Batf relative gene expression in YFP+ and YFP colonic CD4+ T cells 4 weeks after allo-SCT (n = 6 per group). Statistical analyses were performed by unpaired Student t test when comparing between 2 groups and 1-way analysis of variance when comparing over time (mean ± standard error of the mean [SEM]). *P < .05; **P < .01; ***P < .001; ****P < .0001.

Close Modal

or Create an Account

Close Modal
Close Modal